Skip to main content
Norris Cotton Cancer Center
In This Section

Cancer Currents for February 2015

Mark Israel

As we look forward in the New Year, when the importance of science in our lives has never been greater, the public’s inclination toward expediency and self-interest seems to subvert legitimate opportunities to improve medical care through more effective therapeutic interventions. Our nation’s commitment to biological science is eroding, yet the continued impact of cancer, neurodegenerative disease, and infectious illness is unremitting. Examination of the challenges our Cancer Center faces brings into stark relief the importance of identifying and taking full advantage of new strategies to advance knowledge. Our work on the front lines of cancer science will require a different paradigm going forward, one summarized by the phrase “doing more with less.” To not just survive, but thrive, our work must be informed by evolving changes in medical research. By setting higher performance expectations for ourselves at every stage of scientific investigation, standardizing more stringent protocols and enforcing their utilization, and designing experiments to maximize resource utilization we will increase opportunities to be highly productive and competitive for external funding.

Cancer Center leadership is wholly committed to facilitating these efforts by focusing on improving our shared resources, providing less expensive experimental alternatives, building new services, and increasing our revenue opportunities so that meritorious work can be advanced quickly. Recently, the NCI reaffirmed its commitment to evaluate comprehensive cancer centers based on the quality of their work and not necessarily the breadth of their interests. I see this as a mandate for our Cancer Center to prioritize our strengths and facilitate development of our most promising science with an ever more focused allocation of resources.

Our broad research base, intellectual acumen, and collaborative commitment to pursue important scientific questions are key factors in support of the NCCC research enterprise. I look forward to working closely with everyone on our team in 2015 to more efficiently use our resources and more quickly advance our mission.

Mark Israel, Director

New Hires

We are pleased to announce the hire of two Hematology/Oncology physicians who will join the Section of Hematology/Oncology.

Cibar Benitez, MD, will join the NCCC Manchester team in July, 2015. He will work four days at NCCC Manchester and one day at Speare Memorial Hospital in Plymouth, NH providing oncology outreach.

Joshua Rifkind, MD, is returning to NCCC! He will join the NCCC Manchester/NCCC Nashua practices in February, 2015.

January Cancer Center New Members

Cancer Mechanisms Research Program
Erik Griffin, PhD
Assistant Professor of Biological Sciences Dartmouth College

Other Happenings

Northeastern Breast Cancer Symposium

Friday, May 8, 2015, 8:00 am—5:00 pm
Auditorium E, Norris Cotton Cancer Center

Cancer Nanotechnology Symposium: Targeting, Diagnostics & Therapy

Friday, March 27, 2015, 7:45 am–4:00 pm
Auditorium G, Norris Cotton Cancer Center
The symposium is free and open to the public, participants are encouraged to register and contribute posters to be viewed at a lunch-time reception.
For more information, click here.

Grand Rounds

NCCC holds Grand Rounds lectures on most Tuesdays from 12 to 1 pm in the Barbara E. Rubin Building at D-H, Lebanon. Our Events for Cancer Professionals listing shows our upcoming lectures. Most lectures can be viewed live or archived.